Share on StockTwits

Vitamin Shoppe (NYSE:VSI)’s share price reached a new 52-week low during trading on Tuesday following a dissappointing earnings announcement, Analyst Ratings reports. The stock traded as low as $38.78 and last traded at $40.17, with a volume of 1,158,455 shares traded. The stock had previously closed at $43.60.

The company reported $0.62 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.63 by $0.01. The company had revenue of $306.20 million for the quarter, compared to the consensus estimate of $306.09 million. During the same quarter last year, the company posted $0.60 earnings per share. Vitamin Shoppe’s revenue was up 9.6% compared to the same quarter last year.

A number of research firms have recently commented on VSI. Analysts at Morgan Stanley initiated coverage on shares of Vitamin Shoppe in a research note on Tuesday, June 24th. They set an “overweight” rating and a $54.00 price target on the stock. Separately, analysts at Bank of America upgraded shares of Vitamin Shoppe from an “underperform” rating to a “neutral” rating in a research note on Wednesday, June 4th. They now have a $47.00 price target on the stock. Finally, analysts at Barclays upgraded shares of Vitamin Shoppe from an “equal weight” rating to an “overweight” rating in a research note on Friday, May 9th. They now have a $51.00 price target on the stock, up previously from $49.00. Five research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $52.84.

The stock has a 50-day moving average of $43.54 and a 200-day moving average of $44.68. The company has a market cap of $1.217 billion and a price-to-earnings ratio of 20.08.

Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.